Streszczenie
5/2025
vol. 112
Artykuł oryginalny
Immunogenicity of SARS-CoV-2 Vaccines in Psoriatic Patients on Ongoing Tildrakizumab Therapy: a Monocentric Observational Study
- Center for Inflammatory Skin Diseases, Department of Dermatology, Venereology and Allergology, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Schleswig-Holstein, Germany
- Medical Department I, Department of Rheumatology and Clinical Immunology, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Schleswig-Holstein, Germany
Dermatol Rev/Przegl Dermatol 2025, 112, 279–290
Data publikacji online: 2025/12/30
Dostępne w
Zintergrowane z


